Pages that link to "Q42218621"

The following pages link to Comparing clinical characteristics between hospitalized adults with laboratory-confirmed influenza A and B virus infection (Q42218621):

Displaying 44 items.

• The US Influenza Hospitalization Surveillance Network (Q30378144) (← links)
• Epidemiological features of influenza in Canadian adult intensive care unit patients. (Q30379296) (← links)
• Critically ill patients with H7N9: new virus, old challenges*. (Q34988310) (← links)
• Prediction of influenza B vaccine effectiveness from sequence data (Q36090140) (← links)
• Epidemiology of influenza B in Australia: 2001-2014 influenza seasons (Q37638402) (← links)
• Occupational exposures to influenza among healthcare workers in the United States. (Q38630107) (← links)
• Surges of advanced medical support associated with influenza outbreaks (Q38735773) (← links)
• Community -and hospital laboratory-based surveillance for respiratory viruses (Q39912142) (← links)
• Epidemiology of seasonal influenza infection in pregnant women and its impact on birth outcomes. (Q40048124) (← links)
• Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes. (Q40075978) (← links)
• Outcomes and Susceptibility to Neuraminidase Inhibitors in Individuals Infected With Different Influenza B Lineages: The Influenza Resistance Information Study. (Q40147965) (← links)
• A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Study To Investigate the Safety, Tolerability, and Pharmacokinetics of an Anti-Influenza B Virus Monoclonal Antibody, MHAB5553A, in Healthy Volunteers (Q40180049) (← links)
• A clinical trial of intradermal and intramuscular seasonal influenza vaccination in patients with atopic dermatitis (Q40329113) (← links)
• Quadrivalent influenza vaccines (Q41389931) (← links)
• Literature review of the epidemiology of influenza B disease in 15 countries in the Asia-Pacific region (Q43167533) (← links)
• Influenza vaccine effectiveness against influenza-related hospitalization during a season with mixed outbreaks of four influenza viruses: a test-negative case-control study in adults in Canada (Q47137946) (← links)
• Excess of Mortality in Adults and Elderly and Circulation of Subtypes of Influenza Virus in Southern Brazil (Q47548490) (← links)
• A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B viruses. (Q47608146) (← links)
• Serum High-Mobility-Group Box 1 as a Biomarker and a Therapeutic Target during Respiratory Virus Infections. (Q52657377) (← links)
• Heterogeneous estimates of influenza virus types A and B in the elderly: Results of a meta-regression analysis. (Q54263414) (← links)
• Cost Effectiveness of Quadrivalent Influenza Vaccines Compared with Trivalent Influenza Vaccines in Young Children and Older Adults in Korea (Q57210543) (← links)
• Non-Uniform and Non-Random Binding of Nucleoprotein to Influenza A and B Viral RNA (Q58696851) (← links)
• Universal influenza virus vaccines and therapeutics: where do we stand with influenza B virus? (Q59349310) (← links)
• Cross-lineage protection by human antibodies binding the influenza B hemagglutinin (Q60907369) (← links)
• An IgM antibody targeting the receptor binding site of influenza B blocks viral infection with great breadth and potency (Q60923336) (← links)
• Non-lytic clearance of influenza B virus from infected cells preserves epithelial barrier function (Q61795882) (← links)
• Risk factors associated with severe outcomes in adult hospitalized patients according to influenza type and subtype (Q61796980) (← links)
• In Vitro Properties and Virulence of Contemporary Recombinant Influenza B Viruses Harboring Mutations of Cross-Resistance to Neuraminidase Inhibitors (Q61814450) (← links)
• Comparative Outcomes of Adults Hospitalized With Seasonal Influenza A or B Virus Infection: Application of the 7-Category Ordinal Scale (Q63976769) (← links)
• Unreliable usage of a single influenza virus IgM antibody assay in influenza-like illness: A retrospective study of the 2016-2018 flu epidemic (Q64099538) (← links)
• Characteristics of hospitalized adult patients with laboratory documented Influenza A, B and Respiratory Syncytial Virus - A single center retrospective observational study (Q64108822) (← links)
• Viral Kinetics and Resistance Development in Children Treated with Neuraminidase Inhibitors: The Influenza Resistance Information Study (IRIS) (Q90325454) (← links)
• Molecular characterization of influenza viruses from women and infants in Sarlahi, Nepal (Q90352584) (← links)
• Clinical Characteristics and Prognosis of Influenza B Virus-Related Hospitalizations in Northern China during the 2017-18 Influenza Season: A Multicenter Case Series (Q91900633) (← links)
• Influenza vaccination for Hajj for the next decade: A case for quadrivalent SH vaccine (Q92143040) (← links)
• The Development and Use of Reporter Influenza B Viruses (Q92569973) (← links)
• A molecularly engineered antiviral banana lectin inhibits fusion and is efficacious against influenza virus infection in vivo (Q92608671) (← links)
• Alternating patterns of seasonal influenza activity in the WHO European Region following the 2009 pandemic, 2010-2018 (Q92686393) (← links)
• The impact of incorporating early rapid influenza diagnosis on hospital occupancy and hospital acquired influenza (Q92695814) (← links)
• Development of Influenza B Universal Vaccine Candidates Using the "Mosaic" Hemagglutinin Approach (Q92828089) (← links)
• Severity and outcomes of influenza-related pneumonia in type A and B strains in China, 2013-2019 (Q93160589) (← links)
• Animal models for the risk assessment of viral pandemic potential (Q93241084) (← links)
• The burden of laboratory-confirmed influenza infection in Lebanon between 2008 and 2016: a single tertiary care center experience (Q94595564) (← links)
• Adaptation of influenza B virus by serial passage in human airway epithelial cells (Q98775906) (← links)